Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
002437.SZ
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q1.23
N/A
-0.15
vs 0
Q1.23
+1726%
0.01
vs 0
Q2.23
-65%
0
vs 0.01
Q3.23
+3120%
0.09
vs 0
Q4.23
N/A
-0.05
vs NA
Q1.24
+152%
0.02
vs 0.01
Q2.24
+758%
0.03
vs 0
Q3.24
-71%
0.03
vs 0.09
Q4.24
+146%
0.02
vs -0.05
Q1.25
+16%
0.03
vs 0.02
Sales Growth
YoY
Current
Estimates
Q1.23
-10%
692.9M vs 774.2M
Q1.23
-12%
681.2M vs 774.2M
Q2.23
-9%
751.5M vs 825.4M
Q3.23
-24%
619.3M vs 815.5M
Q4.23
NA
566.2M vs NA
Q1.24
-14%
586.1M vs 681.2M
Q2.24
-18%
618.2M vs 751.5M
Q3.24
+3%
636.2M vs 619.3M
Q4.24
+3%
583.2M vs 566.2M
Q1.25
-6%
551.3M vs 586.1M
Return on Equity
QoQ
Q2.23
+0%
0
vs 0.01
Q3.23
+11%
0.11
vs 0
Q4.23
-6%
-0.06
vs 0.11
Q1.24
+3%
0.03
vs -0.06
Q2.24
+4%
0.04
vs 0.03
Q3.24
+3%
0.03
vs 0.04
Q4.24
+3%
0.03
vs 0.03
Q1.25
+3%
0.03
vs 0.03
Institutionnal Ownership
Forecast
408%2026-Revenue
428%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Quote Panel
Key Metrics
Relative Strength
002437.SZ
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Harbin Gloria Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products primarily in the People's Republic of China. It offers cardiac cerebrovascular medication, skeletal muscle system, vitamins and minerals, urinary system medication, antitumor medication, endocrine medicine, anti-infective drugs, respiratory medication, antihistamine, peptic, and other products. Harbin Gloria Pharmaceuticals Co., Ltd. was founded in 2000 and is based in Harbin, the People's Republic of China.
SHZ
-0.01Â ( -0.32%)
Relative Strenght
Volume Buzz
183%
Earning Acce
No
Dist 52w H.
4%Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 002437.SZ compares to sector?